December 4th 2024
Many unvaccinated adults reported intent to get vaccinated, according to early season estimates released in MMWR.
November 12th 2024
The FDA cleared Novavax to start enrolling the planned phase 3 trial after a safety concern was found to be unrelated to the combination vaccine.
November 11th 2024
Insights on how to manage the "triple threat" of flu, RSV, and COVID-19 this season.
October 7th 2024
Less than one-quarter of people infected with influenza-associated severe acute respiratory illness were vaccinated, according to a new report.
September 30th 2024
Your daily dose of the clinical news you may have missed.
First Self-Administered Flu Vaccine Approved by US FDA
FluMist is the first influenza vaccine that does not have to be given by a health care professional.
FDA Grants Emergency Use Authorization for Updated Novavax COVID-19 Vaccine
The updated COVID-19 vaccine targets the currently circulating Omicron variant JN.1 strain of SARS-CoV-2.
Respiratory Virus Vaccines: A Q&A With AAFP President Steven Furr, MD
Topics include declining vaccine coverage among kindergarten-aged children and key changes in recommendations for adult vaccination.
FDA Grants Approval, EUA for Updated mRNA COVID-19 Vaccines
The updated COVID-19 vaccines will include a monovalent component corresponding to KP.2, a strain of the Omicron variant of SARS-CoV-2.
2024-25 Respiratory Virus Season: AAFP President on How to Get More Shots in Arms
Steven Furr, MD, discusses how communication between clinicians and patients is crucial to combatting vaccine hesitancy this upcoming respiratory virus season.
Respiratory Virus Vaccines: AAFP Board Chair on Patient Eligibility, How to Combat Misinformation this Season
Encouraging patients to reach out with questions may lead more to roll up their sleeves this season, Tochi Iroku-Malize, MD, told Patient Care.
Respiratory Virus Vaccine Update: AAFP Board Chair Details ACIP 2024-25 Recommendations
Tochi Iroku-Malize, MD, discusses the ACIP's updated recommendations for immunization against COVID-19, influenza, and RSV.
7 Drugs Approved for Primary Care: Q2 2024
ICYMI: A quick look at 7 key drugs FDA-approved in the second quarter for conditions commonly seen in primary care.
States with Higher COVID-19 Vaccination Rates Saw Reduction in Pediatric Asthma Prevalence
A new study shows that higher vaccination rates were associated with a decrease in the prevalence of parent-reported asthma symptoms in children.
CDC Updates COVID-19, Influenza Vaccine Recommendations for 2024-2025 Respiratory Virus Season
Individuals 6 months and older should receive updated COVID-19 and influenza vaccines for the 2024-2025 respiratory virus season, the agency recommended.
Moderna Will Have to Wait for FDA Approval of Investigational RSV Vaccine
While Moderna expects mRNA-1345 to be approved later this month, the company cites FDA administrative constraints as reason for delay.
COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone: Daily Dose
Study: COVID-19 Booster Shots Elicit Longer Immunity than Primary Series Alone
Researchers found that the COVID-19 booster dose elicited a 71%-84% increase in the median anti-spike half-life over that of the primary series.
Influenza Vaccine Education in Emergency Departments Improves Uptake, According to New Study
Investigators found vaccine uptake of 41% among unvaccinated individuals who were part of a messaging intervention in the emergency department.
Self-Administered Flu Vaccine May be “Powerful Tool” in Immunization Efforts, Says Expert
Ravi Jhaveri, MD, provides an overview of AstraZeneca's FluMist Quadrivalent vaccine and discusses why it could help increase vaccination rates.
Merck's 21-Valent Adult-Specific Pneumococcal Vaccine Accrues New Phase 3 and Real World Data
The novel 21-valent pneumococcal vaccine remains on track for the FDA PDUFA date of June 17, 2024; Merck adds this new data to the body of positive evidence.
Would you Know Measles if You Saw It?
A case of measles is a very rare diagnosis in the 21st century, but as MMR vaccination rates fall, the cases climb. Would you recognize the signs & symptoms?
This is Measles If You've Never Seen It
Here, the 5 key signs and symptoms that characterize measles in the order of appearance.
Measles and the Collective American Memory: 3 Questions
Measles cases are edging up in the US again as MMR vaccination rates continue to decline. Have parents forgotten the Ohio outbreak of 2022? Have you? Find out, here.
Influenza Vaccines: 4 Questions on What to Order, Which to Use
Influenza continues to rage in some parts of the US; try these 4 quick questions on vaccines you may or may not have on hand.
Updated Monovalent COVID-19 Vaccines Effective Against Symptomatic Infection, Emerging Variants
The updated COVID-19 vaccines were approximately 54% effective against symptomatic SARS-CoV-2 infection, according to new data from the CDC.
Daily Dose: Vaccination Reduces Risk of Long COVID in Children
Vaccination Provides Moderate Protection against Long COVID in Children
Vaccination against SARS-CoV-2 was associated with reduced risk of long COVID for at least 12 months in children and adolescents in a new large retrospective study.
Practice Pearls for Discussing COVID-19 Vaccines with Patients
Drs Tina Q. Tan and Rodney Rohde share final thoughts on addressing patient and parent concerns with COVID-19 vaccines.
mRNA Technology in COVID-19 Vaccine Production
Experts comment on the significance of mRNA (messenger RNA) technology in developing COVID-19 vaccines, as well as vaccines against other viral infections.
Approaching Patient Education About COVID-19 Vaccination
Rodney Rohde, PhD, MS, SM(ASCP)CM, shares his approach to initiating conversations around COVID-19 vaccination to patients and family members, highlighting the safety of administering multiple vaccines at during 1 visit.
Efficacy of Latest COVID-19 Vaccines
Experts discuss the efficacy of the latest vaccines against currently circulating strains of COVID-19, commenting on how long immunity lasts from these vaccines.
The Need for Vaccination Against COVID-19
Drs Tina Q Tan and Rodney Rohde review the importance of vaccinating against COVID-19 to prevent long COVID, as well as highlight the current vaccination recommendations.
Daily Dose: Coadministration of RSV and Influenza Vaccines
Coadministration of RSV, Influenza Vaccines Found Safe and Effective in New Study
The coadministration of RSVpreF and seasonal influenza vaccine was found to generate robust immune responses in older adults, reported authors of new study.